Vsee Health (VSEE) Common Equity (2021 - 2026)

Vsee Health (VSEE) has reported Common Equity for 6 consecutive years, with $7.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 232.36% year-over-year to $7.6 million; the trailing twelve-month figure through Jun 2026 stood at $7.6 million (up 232.36% YoY), and the FY2025 full-year result was $5.5 million, up 29591.39% from the prior year.
• Common Equity grew to $7.6 million in Q2 2026 per VSEE's latest filing, from $6.3 million in the prior quarter.
• Across five years, Common Equity topped out at $7.6 million in Q2 2026 and bottomed at -$18.0 million in Q2 2024.
• Historically, Common Equity has averaged -$2.2 million across 5 years, with a median of -$2.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Common Equity slumped 1934.19% in 2024, then surged 29591.39% in 2025.
• Over 5 years, Common Equity stood at -$574066.0 in 2022, then plunged by 648.96% to -$4.3 million in 2023, then jumped by 99.57% to -$18488.0 in 2024, then soared by 29591.39% to $5.5 million in 2025, then jumped by 39.26% to $7.6 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $7.6 million, $6.3 million, and $5.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.